Results 251 to 260 of about 2,047,298 (354)

The New Reference Material CRM 470 for Standardizafion of Immunoassays for Plasma Proteins

, 1996
S Baudner, Francesco Dati
openalex   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Material Recycling of Polymer Materials and Material Properties of the Recycled Materials

NIPPON GOMU KYOKAISHI, 2014
openaire   +2 more sources

Comparative Analysis of Restorative Interior Design Elements: Screen-Based Versus Virtual Reality Evaluations for Future Medical Treatment Prospects. [PDF]

Int J Environ Res Public Health
Tural A, Tural E.
europepmc   +1 more source

Erratum to “Lattice distortion and thermoelectric property for Zn_1-(x+y)Ga_xIn_yO system (x + y = 0.007, 0 ≤ x ≤ 0.007, 0 ≤ y ≤ 0.007)” [Transactions of the Materials Research Society of Japan 37 [3] 399-403 (2012)]

, 2013
H. Takemoto, Hiroshi Kawakami, Masataka Saito, Hiroshi Yamamura   +3 more
openalex   +2 more sources

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Lifelines and Gateways: The Relational Affordances of Arctic Airports. [PDF]

J Contemp Ethnogr
Meyer A, Adams RM, Elixhauser S.
europepmc   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

Staff Accounting Bulletin 92: A Paradigmatic Shift in Disclosure Standards [PDF]

, 1996
Ching, Peter N, Diglio, Brian M
core   +1 more source

Advanced Methods, Materials, and Devices for Microfluidics

, 2003
Celesta E. White
openalex   +1 more source